Correlation Between Theseus Pharmaceuticals and G1 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Theseus Pharmaceuticals and G1 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Theseus Pharmaceuticals and G1 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Theseus Pharmaceuticals and G1 Therapeutics, you can compare the effects of market volatilities on Theseus Pharmaceuticals and G1 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Theseus Pharmaceuticals with a short position of G1 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Theseus Pharmaceuticals and G1 Therapeutics.
Diversification Opportunities for Theseus Pharmaceuticals and G1 Therapeutics
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Theseus and GTHX is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Theseus Pharmaceuticals and G1 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on G1 Therapeutics and Theseus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Theseus Pharmaceuticals are associated (or correlated) with G1 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of G1 Therapeutics has no effect on the direction of Theseus Pharmaceuticals i.e., Theseus Pharmaceuticals and G1 Therapeutics go up and down completely randomly.
Pair Corralation between Theseus Pharmaceuticals and G1 Therapeutics
If you would invest 715.00 in G1 Therapeutics on September 19, 2024 and sell it today you would earn a total of 0.00 from holding G1 Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Theseus Pharmaceuticals vs. G1 Therapeutics
Performance |
Timeline |
Theseus Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
G1 Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Theseus Pharmaceuticals and G1 Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Theseus Pharmaceuticals and G1 Therapeutics
The main advantage of trading using opposite Theseus Pharmaceuticals and G1 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Theseus Pharmaceuticals position performs unexpectedly, G1 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in G1 Therapeutics will offset losses from the drop in G1 Therapeutics' long position.Theseus Pharmaceuticals vs. Relay Therapeutics | Theseus Pharmaceuticals vs. Century Therapeutics | Theseus Pharmaceuticals vs. Blueprint Medicines Corp | Theseus Pharmaceuticals vs. Pmv Pharmaceuticals |
G1 Therapeutics vs. Allogene Therapeutics | G1 Therapeutics vs. Heron Therapeuti | G1 Therapeutics vs. Annexon | G1 Therapeutics vs. Sangamo Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |